Expand to
New Markets
using AI

OntoPharma maintains a 99.8% accuracy rate for regulatory pathway analysis. Our AI engine is trained on a comprehensive database of global regulatory requirements that is updated in real-time. We analyze thousands of successful drug applications and continuously improve our algorithms based on regulatory outcomes.

For added confidence, all pathways generated by our AI undergo validation checks against the latest regulatory guidelines before being presented to users. In the rare event of discrepancies, our system flags potentially ambiguous requirements for manual review by regulatory experts.

Yes, OntoPharma is designed to analyze both simple and complex drug formulations, including those with multiple active pharmaceutical ingredients (APIs). Our system can process combination products and identify the regulatory requirements specific to each component as well as the combined formulation.

We support various input formats including molecular formulas, SMILES notation, and common pharmaceutical names. For highly complex formulations, our Professional and Enterprise plans offer advanced analysis capabilities that can identify potential interactions between components and their regulatory implications.

OntoPharma covers major global regulatory agencies including the FDA (US), EMA (European Union), Health Canada, PMDA (Japan), TGA (Australia), NMPA (China), and many others. Our database includes regulatory requirements for over 100 countries worldwide.

The specific market coverage depends on your subscription tier:

• Starter Plan: Choose one primary market region
• Professional Plan: Includes FDA, EMA, and Health Canada
• Enterprise Plan: Comprehensive global coverage

OntoPharma's document generation feature creates agency-specific regulatory documents based on your drug composition and intended markets. The system auto-populates technical information, safety data, and required regulatory content into standardized templates that comply with each agency's formatting requirements.

Documents are generated in editable formats, allowing your team to review and refine the content before submission. The system includes:

• Application forms and cover letters
• Chemistry, Manufacturing and Controls (CMC) documentation
• Safety assessment templates
• Clinical study protocol outlines
• Product labeling drafts
• Controlled substance handling protocols (when applicable)

For most standard drug compositions, OntoPharma generates a comprehensive regulatory roadmap within seconds of submission. Our AI processes your drug's chemical formula immediately and produces a detailed, step-by-step licensing pathway tailored to your specific compound and target markets.

For highly complex or novel compounds that may require additional analysis, the process typically takes no more than 2-3 minutes. Enterprise clients with custom regulatory needs may have roadmaps reviewed by our expert team, which can take up to 24 hours for the initial setup, but subsequent updates remain instantaneous.

Absolutely. OntoPharma implements enterprise-grade security measures to protect your confidential drug formulation data. All data is encrypted both in transit and at rest using AES-256 encryption. Our platform is HIPAA compliant and undergoes regular third-party security audits.

We maintain strict data segregation between clients, and your proprietary information is never shared or used to train our AI models without explicit permission. Enterprise clients can also opt for dedicated instances with enhanced security protocols or on-premises deployment options.

Yes, OntoPharma has specialized remediation tools for previously rejected applications. Our system can analyze rejection letters and deficiency notices to identify specific compliance gaps. The AI then generates targeted recommendations to address each concern raised by regulators.

This remediation feature is available on Professional and Enterprise plans. For complex rejection cases, Enterprise clients receive additional support from our regulatory affairs specialists who can provide strategic guidance on the resubmission approach.

Our regulatory monitoring system continuously tracks updates from global agencies that could impact your drug's compliance status. The AI analyzes regulatory changes, guidance documents, and enforcement trends to identify those relevant to your specific compounds.

When a relevant change is detected, the system:

• Sends real-time alerts via email and in-platform notifications
• Provides an impact analysis specific to your drug
• Updates your regulatory roadmap with new requirements
• Suggests modifications to existing documentation
• Estimates timeline impacts for ongoing applications

This feature is available on Professional and Enterprise plans, with Enterprise clients receiving additional customization options for monitoring parameters.